Boston Partners Sight Sciences, Inc. Transaction History

Boston Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$2.88 - $8.8 $28,566 - $87,287	9,919 Added 3.08%	331,776 $1.12 Million
Q2 2023 Aug 10, 2023	BUY	$7.46 - $10.67 $487,443 - $697,188	65,341 Added 25.47%	321,857 $2.66 Million
Q1 2023 May 09, 2023	SELL	$8.44 - $13.35 $364,920 - $577,213	-43,237 Reduced 14.42%	256,516 $2.24 Million
Q4 2022 Feb 07, 2023	BUY	$5.58 - $13.94 $261,573 - $653,465	46,877 Added 18.54%	299,753 $3.66 Million
Q3 2022 Nov 09, 2022	BUY	$6.1 - $11.41 $712,004 - $1.33 Million	116,722 Added 85.73%	252,876 $1.61 Million
Q2 2022 Aug 10, 2022	BUY	$6.61 - $11.99 $899,977 - $1.63 Million	136,154 New	136,154 $1.22 Million

21.4M

30.7K

18.6K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $287M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.